Prior to joining Professor Louise Purton’s Stem Cell Regulation laboratory at SVI, I completed a Bachelor (Honours) in Biomedical Science and a PhD in Medicine at the University of Sydney, and then spent one year as a light microscopist at the University’s Sydney Microscopy and Microanalysis Unit.
My research is on the bone marrow microenvironment, which is integral to the regulation of blood cell production. Every year, approximately 2000 Australians undergo a bone marrow transplant to treat blood cell cancers and cancer therapies, such as chemotherapy and radiotherapy. These treatments can cause prolonged periods of low blood cell counts, increasing the risk of bleeding, infection and, in severe cases, death. Low blood cell counts are not only life-threatening, but they are also a major reason for delaying further cycles of cancer treatment and significantly contributes to the failure of chemotherapy to control cancers.
These treatments cause damage to the bone marrow microenvironment which regulates blood cell production, but we need to better understand what is damaged. Like a production line, if even one of the parts (aka microenvironment cells) are damaged, it can cause severe downstream effects.
I use advanced microscopy techniques to research the interactions between haematopoietic stem and progenitor cells and the bone marrow microenvironment, and how these are altered by cancer treatments. Through my research, I aim to improve the outcomes of cancer patients undergoing cancer therapies.
Key achievements
2022 Harold Mitchell Travel Award; International Society of Experimental Hematology, New Investigators Oral presentation award, 2nd place
2021 Co-supervised two Honours students to completion (First class); SVI Rising Star Award
2019 Co-supervised a Masters student to completion (First class)
2018 Australian Microscopy and Microanalysis Society, Bursary award
Stem Cell Regulation
Our laboratory does discovery through to translational research, with an ultimate goal to improve therapies for patients with different diseases that affect blood cell production. We study how blood cell production is regulated, both by proteins made by the blood cells themselves and by proteins made by the bone marrow microenvironment, which is the factory where blood cells are produced.
Lab head: Professor Louise PurtonSelected publications
*Green AC, *Tjin G, Lee SC, Chalk AM, Straszkowski L, Kwang D, Baker EK, Quach JM, Kimura T, Wu JY, and Purton LE (2021). “The characterization of distinct populations of murine skeletal cells that have different roles in B lymphopoiesis”. Blood. 138(4):304-317. doi: 10.1182/blood.2020005865 * Co-first authors
Kwang D, Tjin G and Purton LE (2021). “Regulation of murine B lymphopoiesis by stromal cells”. Immunological Reviews. 302(1):47-67. doi: 10.1111/imr.12973
*Tjin G, *Flores-Figueroa E, *Duarte D, Straszkowski L, Scott M, Khorshed RA, Purton LE and Celso, Lo C (2019). “Imaging methods used to study mouse and human HSC niches: current and emerging technologies”. Bone. 119:19-35. doi: 10.1016/j.bone.2018.04.022 * Co-first authors
Green AC, Rudolph-Stringer V, Straszkowski L, Tjin G, Crimeen-Irwin B, Walia M, Martin TJ, Sims NA and Purton LE (2018). “Retinoic Acid Receptor gamma Activity in Mesenchymal Stem Cells Regulates Endochondral Bone, Angiogenesis and B Lymphopoiesis”. J. Bone. Miner. Res. 33(12):2202-2213. doi: 10.1002/jbmr.3558
Tjin G, White ES, Faiz A, Sicard D, Tschumperlin DJ, Mahar A, Kable EPW and Burgess JK (2017). “Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis”. Dis. Model. Mech. 10(11):1301-1312. doi: 10.1242/dmm.030114
Tjin G, Xu P, Kable SH, Kable EPW and Burgess JK (2014). “Quantification of Collagen I in airway tissues using second harmonic generation”. J. Biomed. Opt. 19(3):36005. doi: 10.1117/1.JBO.19.3.036005
ORCID profile: https://orcid.org/0000-0002-7235-6909
Google Scholar profile: https://scholar.google.com/citations?user=6beONWgAAAAJ&hl=en&oi=ao